Archive: 09/09/2014
No convincing evidence to support use of new hip and knee implants
Several new and widely used hip and knee implants appear to have no clinically relevant improved benefits compared with older, more established implants, according to a review of the evidence published in BMJ today.
Sep 9, 2014
Host protein levels correlate with HIV-associated neurocognitive disorder
Combination antiretroviral therapy has dramatically increased the life expectancy for HIV-infected patients. However, the prevalence of HIV-associated neurocognitive disorders, which may be triggered by inflammation in the ...
Sep 9, 2014
Mesothelial cells promote ovarian cancer metastasis
Less than half of the women diagnosed with ovarian cancer will survive beyond 5 years. Ovarian cancer readily spreads to abdominal organs, which are covered by a layer of cells called the mesothelium. Ovarian cancer cells ...
Sep 9, 2014
Researchers urge new payment model for gene therapy
Hoping to encourage sufficient investments by pharmaceutical companies in expensive gene therapies, which often consist of a single treatment, a Penn researcher and the chief medical officer of CVS Health outline an alternative ...
Sep 9, 2014
Discovery paves the way for a new generation of chemotherapies
A new mechanism to inhibit proteasomes, protein complexes that are a target for cancer therapy, is the topic of an article published in the journal Chemistry & Biology. The first author of the study is Daniela Trivella, researcher ...
Sep 9, 2014
University of Washington biotech start-up to develop game-changing cancer therapies
Taiwan-based BRIM (Beyond Research and Innovative Medicines) Biotechnology has entered into an agreement with UW biotech start-up Compliment Corporation to develop Compliment's two oncology platform technologies based on ...
Sep 9, 2014